Oncolytics Biotech Inc.
ONCY
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.94
FAIR PRICE
$0.47
MARGIN
$0.47
P/E Ratio
N/A
Div. Yield
N/A
ROE
-755.2%
Average
Market Cap
$118M
Small-cap
COMING SOON
Get notified when ONCY's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Jared Kelly
COUNTRY
CA
HEADQUARTERS
Calgary
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate ONCY's fair price
Oncolytics Biotech Inc.'s fair price of $0.47 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.94, ONCY trades 49.9% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting ONCY's risk profile.
RELATIVE · 30%
Comparing ONCY's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for ONCY, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate ONCY's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for ONCY.
Explore on BuliosFAQ
What is the fair price of ONCY?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Oncolytics Biotech Inc. is $0.47. At the current market price of $0.94, ONCY trades 49.9% above its calculated fair value.
Is ONCY overvalued or undervalued?+
Oncolytics Biotech Inc. is currently overvalued based on our valuation model. The stock trades at $0.94, which is 49.9% above the fair price of $0.47.
How often is ONCY's fair price updated?+
We update fair price calculations for ONCY daily after market close. The current fair price of $0.47 incorporates the latest market data and sector multiples.
What factors affect ONCY's fair price calculation?+
ONCY's fair price of $0.47 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -755.2%.
Is ONCY a good buy right now?+
At $0.94, ONCY trades 49.9% above our fair value estimate of $0.47. The stock is currently overvalued. ROE stands at -755.2% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does ONCY pay dividends?+
ONCY does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.